This is supported by a study using a mouse model of diet-induced obesity, where hypermethylation of the Igfbp2 promoter and reduced Igfbp2 gene expression in early life correlated with the development of fatty liver and impaired glucose metabolism in adolescence [21]. Here, IGFBP2 is linked to medical procedure.